Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-07 11:58 am Sale | 2025-09-30 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 268,564 1.600% | -587,818 (-68.64%) | Filing History |
| 2025-06-04 5:06 pm Purchase | 2025-06-03 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 9,764,864 48.000% | 9,764,864 (New Position) | Filing History |
| 2025-05-14 09:26 am Purchase | 2025-03-31 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 856,382 5.400% | 268,564 (+45.69%) | Filing History |
| 2025-03-07 4:07 pm Purchase | 2025-03-05 | 13D | Elicio Therapeutics, Inc. ELTX | Chudnovsky Yekaterina | 9,657,539 48.100% | 9,657,539 (New Position) | Filing History |
| 2025-02-05 11:10 am Purchase | 2025-01-30 | 13G | Elicio Therapeutics, Inc. ELTX | Knoll Capital Management LP | 630,915 5.200% | 630,915 (New Position) | Filing History |
| 2025-01-07 4:30 pm Purchase | 2023-12-08 | 13G | Elicio Therapeutics, Inc. ELTX | Actyus Private Equity SGIIC, S.A. | 587,818 5.450% | 587,818 (New Position) | Filing History |
| 2024-08-14 5:01 pm Unchanged | 2024-08-14 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-07-02 4:39 pm Unchanged | 2024-07-02 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-10 4:01 pm Unchanged | 2024-04-10 | 13D | Elicio Therapeutics, Inc. ELTX | Clal Biotechnology Industries Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-20 9:07 pm Unchanged | 2024-03-20 | 13D | Elicio Therapeutics, Inc. ELTX | Clal Biotechnology Industries Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-20 4:37 pm Unchanged | 2024-03-20 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-27 4:07 pm Unchanged | 2023-12-27 | 13D | Elicio Therapeutics, Inc. ELTX | Clal Biotechnology Industries Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-26 4:25 pm Unchanged | 2023-12-26 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-30 5:16 pm Unchanged | 2023-08-30 | 13D | Elicio Therapeutics, Inc. ELTX | Clal Biotechnology Industries Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-07-07 09:17 am Unchanged | 2023-07-07 | 13G | Elicio Therapeutics, Inc. ELTX | Vifor (International) Ltd | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-14 4:04 pm Unchanged | 2023-06-14 | 13D | Elicio Therapeutics, Inc. ELTX | Elicio Therapeutics Inc. ELTX | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-14 2:42 pm Unchanged | 2023-06-14 | 13D | Elicio Therapeutics, Inc. ELTX | GKCC, LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-12 4:01 pm Unchanged | 2023-06-12 | 13D | Elicio Therapeutics, Inc. ELTX | Clal Biotechnology Industries Ltd. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:23 pm Unchanged | 2023-02-14 | 13G | Elicio Therapeutics, Inc. ELTX | Goldberg Itzhak | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 12:12 pm Unchanged | 2023-02-14 | 13G | Elicio Therapeutics, Inc. ELTX | EISA-ABC LLC | 0 0.000% | 0 (Unchanged) | Filing |